Enclosed Outcome of Board Meeting dated 5 November 2026

November 5, 2026 To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Dalal Street, ‘Exchange Plaza’ Bandra Kurla Complex, Mumbai – 400 001 Bandra (East) Mumbai 400051 Scrip Code: 508954 NSE Symbol: FINKURVE Subject: Outcome of Board Meeting held on November 5, 2026: Dear Sir(s) / Madam(s), In terms of Regulations 30, 33, 52 and 54 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), as amended from time to time we would like to inform that the Board of Directors of the Company, at their meeting held today, i.e., November 5, 2026, have inter- alia considered and approved the following: 1. Unaudited Financial Results of the Company pursuant to Regulation 33 and 52 of LODR for the quarter and half year ended September 30, 2026. A copy of the said results along with the Limited Review Report thereon issued by the Statutory Auditors of the Company M/s Ladha Singhal & Associates, Chartered Accountants are enclosed herewith as “Annexure 1” and will be uploaded on the Company’s website i.e. www.arvog.com; 2. Security Cover Certificate issued by M/s. Ladha Singhal & Associates, Chartered Accountants, Statutory Auditors, pursuant to Regulation 54 of LODR, read with SEBI Master Circular SEBI/HO/DDHS-PoD-1/P/CIR/2025/117 dated August 13, 2025, as amended, for the quarter and half year ended September 30, 2026, and is enclosed herewith as “Annexure 2”; 3. A statement indicating utilization of issue proceeds and deviation or variation in use of issue proceeds of Preferential Issue of Equity Shares and Share Warrant on Private Placement Basis from the objects of the issue under Regulation 32 (1) and is enclosed herewith as “Annexure 3” 4. A statement indicating utilization of issue proceeds and deviation or variation in use of issue proceeds of non-convertible securities from the objects of the issue under Regulation 52(7) & 52(7A) r/w SEBI Master Circular dated 21st May, 2024 and is enclosed herewith as “Annexure 4”; 5. Approval of adoption of change of Brand Name from ‘ARVOG’ to ‘AUGMONT’. The meeting of Board of Directors commenced at 05:00 P.M. and concluded at 06:30 P.M. (IST) Kindly take this information on record. Thanking you. Yours truly, For Finkurve Financial Services Limited Kajal Parmar Company Secretary & Compliance Officer Membership No. A65484 Annexure 3 Statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. Name of listed entity Finkurve Financial Services Limited Mode of Fund Raising Preferential Issue of Equity Shares and Share Warrants on Private Placement Basis Date of Raising Funds May 21, 2025, and May 27, 2025 Amount Raised Rs. 141.50 Crore Report filed for Quarter ended September 30, 2026 Monitoring Agency Applicable Monitoring Agency Name, if applicable CRISIL Rating Limited Is there a Deviation / Variation in use of No funds raised If yes, whether the same is pursuant to - change in terms of a contract or objects, which was approved by the shareholders If Yes, Date of shareholder Approval - Explanation for the Deviation / Variation - Comments of the Audit Committee after - review Comments of the auditors, if any - Objects for which funds have been raised Not Applicable and where there has been a deviation, in the following table Original Modified Original Modified Funds Amount of Remarks if any Object Object, if Allocation allocation, Utilised Deviation/ any (Rs. In if any (Rs. In Variation Crore) Crore) for the quarter according applicable object Onward NA 141.50 NA 111.50 NA NA lending and (Rs. 30cr investment being 75% and of the share repayment warrants of subscription borrowing amount yet obtained to be by received) company in ordinary course of business Deviation or variation could mean: (a) Deviation in the objects or purposes for which the funds have been raised or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed or (c) Change in terms of a contract referred to in the fund-raising document i.e. prospectus, letter of offer, etc. Annexure 4 Statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. Name of listed entity Finkurve Financial Services Limited Mode of Fund Raising Non-Convertible Debentures Date of Raising Funds i.e. Date of July 29, 2026 Allotment Amount Raised (In Crore) Rs. 26 crore Report filed for Quarter ended September 2026 Monitoring Agency Not Applicable Monitoring Agency Name, if applicable Not Applicable Is there a Deviation / Variation in use of No funds raised If yes, whether the same is pursuant to - change in terms of a contract or objects, which was approved by the shareholders If Yes, Date of shareholder Approval - Explanation for the Deviation / Variation - Comments of the Audit Committee after - review Comments of the auditors, if any - Objects for which funds have been raised Not Applicable and where there has been a deviation, in the following table Original Modified Original Modified Funds Amount of Remarks if any Object Object, if Allocation allocation, Utilised Deviation/ any (Rs. In if any (Rs. In Variation Crore) Crore) for the quarter according to applicable object For NA 26 NA 26 NA NA lending business of the Company Deviation or variation could mean: (d) Deviation in the objects or purposes for which the funds have been raised or (e) Deviation in the amount of funds actually utilized as against what was originally disclosed or Change in terms of a contract referred to in the fund-raising document i.e. prospectus, letter of offer, etc.